Predictors of Death in Patients with H1N1 Influenza: A Retrospective Analytical Study

Document Type : Original Research

Authors
1 Student Research Committee, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran.
2 Nursing and Midwifery Care Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
3 Department of Epidemiology and Biostatistics, Faculty of Health, Mashhad University of Medical Sciences, Mashhad, Iran
4 Department of Medical-Surgical Nursing, Faculty of Nursing and Midwifery, Mazandaran University of Medical Sciences, Sari, Iran.
Abstract
Aims: Influenza A virus subtype H1N1, known as H1N1 influenza virus, could cause moderate to severe swine influenza in humans. H1N1 influenza is associated with high mortality rate. Effective symptom management could significantly reduce the mortality rate. This study aimed to determine the clinical manifestations, outcomes, and predictors of mortality in patients with H1N1 influenza, admitted to hospitals during January to September 2016.

Materials & Methods: This retrospective descriptive-analytical study was conducted during January to September 2016 in eight hospitals located in Razavi Khorasan province, northeastern Iran. The medical records of 65 patients were retrieved, and the necessary data were extracted from the records using a demographic questionnaire and a clinical manifestations checklist. The SPSS software Version 23.0 was used to analyze the data via the measures of descriptive statistics and the logistic regression analysis with odds ratio.

findings: The most common clinical manifestations of H1N1 influenza were headache (70.8%), numbness in the extremities (63.1%), myalgia (60%), cough (58.5%), fever and shivering (53.8%), and nausea (53.8%). In total, 14 (21.53%) patients had died due to H1N1 influenza. The significant predictors of death were dyspnea (OR: 13.91, p: .032), myalgia (OR: 0.04. p: .010), and age (OR: 1.05, p: .024) so that dyspnea and myalgia were associated with 13.9 and 0.04 times higher odds of death, respectively. Moreover, each one year increase in age was associated with 5% increase in the odds of experiencing death.

Conclusions: In the case of H1N1 influenza epidemics, care services need to be allocated more to patients who have higher age and suffer from myalgia and dyspnea.

Keywords


[1] Boon HL and Tahir AM. Influenza A H1N1 2009 (Swine Flu) and Pregnancy. Federation of Obstetrics and Gynaecological Societies of India (FOGSI), 2011; 61(4): 386-396.
[2] Rewar S, Mirdha D and Rewar P. Treatment and Prevention of Pandemic H1N1 Influenza. Annals of Global Health, 2015; 81: 645-653.
[3] Johnson, N.P. and J. Mueller, Updating the accounts: global mortality of the 1918-1920" Spanish" influenza pandemic. Bulletin of the History of Medicine, 2002; 76(1): 105-115.
[4] Soto Mas F, Olivarez A, Jacobson HE, Hsu CE and Miller J. Risk communication and college students: The 2009 H1N1 pandemic influenza. Preventive Medicine, 2011; 52: 473-474.
[5] Behnaz F, Mohammadzadeh M and Sadeghian M. Household transmission of 2009 H1N1 influenza virus in Yazd, Iran. Journal of Infection and Public Health, 2012; 5(4): 275-280.
[6] Crank MC, Gordon IJ, Yamshchikov GV, Sitar S, Hu Z, Enama ME, Holman LA, Bailer RT, Pearce MB, Koup RA, Mascola JR. Phase 1 study of pandemic H1 DNA vaccine in healthy adults. PloS one. 2015 Apr 17;10(4):e0123969.
[7] Zairina AR, Nooriah MS and Yunus AM. Knowledge and practices towards influenza A (H1N1) among adults in three residential areas in Tampin Negeri Sembilan: a cross sectional survey. Med J Malaysia, 2011; 66(3): 207.
[8] Yang TH, Chu D, Hu BS, Hung YT and Chou P. Early experience of the pandemic influenza H1N1 2009 epidemic in Taiwan. Journal of the Chinese Medical Association, 2011; 74(7): 298-304.
[9] Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, Liang ZA, Liang L, Zhang SJ, Zhang B, Gu L. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. New England Journal of Medicine. 2009 Dec 24;361(26):2507-17
[10] Singh A, Khera K, Agarwal J, Awasthi S, Francis JM, Thunga G, Bhat R. Descriptive Analysis of Mortality Predictors in H1n1 Influenza in South Indian Patients. Infectious disorders drug targets Journal.2017 Apr. 10.2174/1871526517666170407155558
[11] Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R. et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA, 2009; 302(17): 1896-1902.
[12] Team NS-OIAVI. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. New England journal of medicine. 2009;360(25):2605-15.
[13] Arbat, S., Dave, M., Niranjane, V. et al. Analyzing the clinical profile of swine flu/influenza A H1N1 infection in central India: a retrospective study. VirusDis. 28,33–38(2017) doi:10.1007/s13337-017-0363-y.
[14] Mata-Marín LA, Mata-Marín JA, Vásquez-Mota VC, et al. Risk factors associated with mortality in patients infected with influenza A/H1N1 in Mexico. BMC Res Notes. 2015;8:432. Published 2015 Sep 11. doi:10.1186/s13104-015-1349-8
[15] Kumar A, Zarychanski R, Pinto R, Cook D, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon A, Lapinsky S, Ahern S, Smith O, Siddiqui F, Jouvet P, Khwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, Meade M, Hall R, Fowler R. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA. 2009;302:1872–1879. doi: 10.1001/jama.2009.1496
[16] Myers KP, Olsen CW, Setterquist SF, Capuano AW, Donham KJ and Thacker EL. Are swine workers in the United States at increased risk of infection with zoonotic influenza virus? Clinical infectious diseases, 2006; 42(1): 14-20.
[17] Pebody RG, McLean E, Zhao H, Cleary P, Bracebridge S, Foster K, et al. Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Eurosurveillance, 2010; 15(20): 19571.
[18] Vaillant L, La Ruche G, Tarantola A, Barboza P; epidemic intelligence team at InVS. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Eurosurveillance, 2009; 14(33): 19309.
[19] Bettinger JA, Sauvé LJ, Scheifele DW, Moore D, Vaudry W, Tran D, Halperin SA and Pelletier L. Pandemic influenza in Canadian children: a summary of hospitalized pediatric cases. Vaccine, 2010; 28(18): 3180-3184.
[20] Lemaitre M and Carrat F. Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic. BMC infectious diseases, 2010; 10(1): 162.
[21] Van Kerkhove MD, Vandemaele KAH, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly ChA, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS medicine, 2011; 8(7): e1001053.
[22] Bulgakova VA, Poromov AA, Grekova AI, Pshenichnaya NY, Selkova EP, Lvov NI, et al. Pharmacoepidemiological study of the course of influenza and other acute respiratory viral infections in risk groups. Ter Arkh, 2017; 89(1): 62-71.
[23] Cholewinska G, Higersberger J, Podlasin R, Wiercinska-Drapało A, Lipowski D, Olszynska-Krowicka M, et al. Clinical manifestations, diagnosis and treatment of swine flu (A/H1N1) infection among patients hospitalized in the Hospital of Infectious Diseases in Warsaw in 2009. Przegl Epidemiol, 2010; 64(1): 9-15.
[24] Alavi SM, Nashibi R and Moradpoor F. Prevalence and Mortality of Influenza A (H1N1) Virus Among Patients With Acute Respiratory Infection in Southwest Iran. Jundishapur J Microbiol, 2014; 7(4): e9263.